Literature DB >> 2229039

Amino acid sequence and characterization of a heparin-binding neurite-promoting factor (p18) from bovine brain.

M D Kuo1, Y Oda, J S Huang, S S Huang.   

Abstract

A neurite-promoting factor (p18) was isolated from bovine brain using ammonium sulfate fractionation, sulfated Sephadex G-50 chromatography, heparin-Sepharose gel chromatography, and reverse phase high performance liquid chromatography. The complete amino acid sequence of p18 was determined by automated Edman degradation of S-pyridylethylated p18, and its peptide fragments produced by cyanogen bromide cleavage and by digestion with specific endoproteinases. Alignment of the amino acid sequences of these peptides revealed that p18 consists of 119 amino acid residues with a calculated molecular weight of 14,200. p18 appears to possess five disulfide bonds per molecule. A region of amino acid sequence at the C terminus of p18 shows a structural feature homologous to that around the reactive sites of Kazal-type protease inhibitors. However, p18 did not exhibit anti-trypsin activity. p18 showed very little, if any, mitogenic activity toward NIH 3T3 cells and Swiss mouse 3T3 cells. p18 was found to bind to a specific receptor with an apparent Kd of approximately 8 nM and receptor numbers 1.7 x 10(5) and 1.0 x 10(4) for NIH 3T3 cells and PC12 cells (rat pheochromocytoma cells), respectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229039

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Structural and functional characterization of full-length heparin-binding growth associated molecule.

Authors:  B S Hampton; D R Marshak; W H Burgess
Journal:  Mol Biol Cell       Date:  1992-01       Impact factor: 4.138

2.  1α,25-Dihydroxyvitamin D(3) down-regulates pleiotrophin messenger RNA expression in osteoblast-like cells.

Authors:  M Tamura; F Ichikawa; R P Guillerman; T F Deuel; M Nodal
Journal:  Endocrine       Date:  1995-01       Impact factor: 3.633

Review 3.  Molecular and pharmacologic targeting of angiogenesis factors--the example of pleiotrophin.

Authors:  F Czubayko; A M Schulte; S C Missner; S S Hsieh; K J Colley; A Wellstein
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

4.  Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice.

Authors:  A K Chauhan; Y S Li; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

Review 5.  The potential role of the heparin-binding growth factor pleiotrophin in breast cancer.

Authors:  A T Riegel; A Wellstein
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 6.  Growth factor targeted and conventional therapy of breast cancer.

Authors:  A Wellstein
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

7.  Pleiotrophin is expressed in avian somites and tendon anlagen.

Authors:  Venugopal Rao Mittapalli; Bodo Christ; Felicitas Pröls; Martin Scaal
Journal:  Histochem Cell Biol       Date:  2009-06-14       Impact factor: 4.304

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.